219 related articles for article (PubMed ID: 19888321)
1. Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients.
Wei BR; Hoover SB; Ross MM; Zhou W; Meani F; Edwards JB; Spehalski EI; Risinger JI; Alvord WG; Quiñones OA; Belluco C; Martella L; Campagnutta E; Ravaggi A; Dai RM; Goldsmith PK; Woolard KD; Pecorelli S; Liotta LA; Petricoin EF; Simpson RM
PLoS One; 2009 Oct; 4(10):e7670. PubMed ID: 19888321
[TBL] [Abstract][Full Text] [Related]
2. S100A6 as a potential serum prognostic biomarker and therapeutic target in gastric cancer.
Zhang J; Zhang K; Jiang X; Zhang J
Dig Dis Sci; 2014 Sep; 59(9):2136-44. PubMed ID: 24705642
[TBL] [Abstract][Full Text] [Related]
3. Proteomics detection of S100A6 in tumor tissue interstitial fluid and evaluation of its potential as a biomarker of cholangiocarcinoma.
Onsurathum S; Haonon O; Pinlaor P; Pairojkul C; Khuntikeo N; Thanan R; Roytrakul S; Pinlaor S
Tumour Biol; 2018 Apr; 40(4):1010428318767195. PubMed ID: 29629840
[TBL] [Abstract][Full Text] [Related]
4. S100A6 promotes cell proliferation in human nasopharyngeal carcinoma via the p38/MAPK signaling pathway.
Li A; Shi D; Xu B; Wang J; Tang YL; Xiao W; Shen G; Deng W; Zhao C
Mol Carcinog; 2017 Mar; 56(3):972-984. PubMed ID: 27596819
[TBL] [Abstract][Full Text] [Related]
5. LC-MS/MS analysis of ovarian cancer metastasis-related proteins using a nude mouse model: 14-3-3 zeta as a candidate biomarker.
He Y; Wu X; Liu X; Yan G; Xu C
J Proteome Res; 2010 Dec; 9(12):6180-90. PubMed ID: 21028892
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic significance of S100A2 and S100A6 levels in sera of patients with non-small cell lung cancer.
Wang T; Liang Y; Thakur A; Zhang S; Yang T; Chen T; Gao L; Chen M; Ren H
Tumour Biol; 2016 Feb; 37(2):2299-304. PubMed ID: 26361956
[TBL] [Abstract][Full Text] [Related]
7. High Expression of S100A6 Predicts Unfavorable Prognosis of Lung Squamous Cell Cancer.
He X; Xu X; Khan AQ; Ling W
Med Sci Monit; 2017 Oct; 23():5011-5017. PubMed ID: 29053662
[TBL] [Abstract][Full Text] [Related]
8. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
[TBL] [Abstract][Full Text] [Related]
9. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
[TBL] [Abstract][Full Text] [Related]
10. Serum S100A6, S100A8, S100A9 and S100A11 proteins in colorectal neoplasia: results of a single centre prospective study.
Moravkova P; Kohoutova D; Vavrova J; Bures J
Scand J Clin Lab Invest; 2020 May; 80(3):173-178. PubMed ID: 31856598
[TBL] [Abstract][Full Text] [Related]
11. Identification of multiple novel protein biomarkers shed by human serous ovarian tumors into the blood of immunocompromised mice and verified in patient sera.
Beer LA; Wang H; Tang HY; Cao Z; Chang-Wong T; Tanyi JL; Zhang R; Liu Q; Speicher DW
PLoS One; 2013; 8(3):e60129. PubMed ID: 23544127
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation, modification, and translocation of S100A6 induced by exposure to ionizing radiation revealed by proteomics profiling.
Orre LM; Pernemalm M; Lengqvist J; Lewensohn R; Lehtiö J
Mol Cell Proteomics; 2007 Dec; 6(12):2122-31. PubMed ID: 17785350
[TBL] [Abstract][Full Text] [Related]
13. S100A6 protein: functional roles.
Donato R; Sorci G; Giambanco I
Cell Mol Life Sci; 2017 Aug; 74(15):2749-2760. PubMed ID: 28417162
[TBL] [Abstract][Full Text] [Related]
14. Serum expression of S100A6 is a potential detection marker in patients with urothelial carcinoma in the urinary bladder.
Nishi M; Matsumoto K; Kobayashi M; Yanagita K; Matsumoto T; Nagashio R; Ishii D; Fujita T; Sato Y; Iwamura M
Biomed Res; 2014; 35(6):351-6. PubMed ID: 25743341
[TBL] [Abstract][Full Text] [Related]
15. Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery.
Pitteri SJ; JeBailey L; Faça VM; Thorpe JD; Silva MA; Ireton RC; Horton MB; Wang H; Pruitt LC; Zhang Q; Cheng KH; Urban N; Hanash SM; Dinulescu DM
PLoS One; 2009 Nov; 4(11):e7916. PubMed ID: 19936259
[TBL] [Abstract][Full Text] [Related]
16. S100A6 expression and function in human osteosarcoma.
Luo X; Sharff KA; Chen J; He TC; Luu HH
Clin Orthop Relat Res; 2008 Sep; 466(9):2060-70. PubMed ID: 18612712
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of S100A6 in oral squamous cell carcinoma.
Yang X; Wei KJ; Zhang L; Pan HY; Ye DX; Zhong LP; Zhang ZY
Oncol Rep; 2010 Aug; 24(2):479-88. PubMed ID: 20596636
[TBL] [Abstract][Full Text] [Related]
18. Discovery of serum biomarkers implicated in the onset and progression of serous ovarian cancer in a rat model using iTRAQ technique.
Huang Y; Zhang X; Jiang W; Wang Y; Jin H; Liu X; Xu C
Eur J Obstet Gynecol Reprod Biol; 2012 Nov; 165(1):96-103. PubMed ID: 22818854
[TBL] [Abstract][Full Text] [Related]
19. A Targeted Mass Spectrometry Strategy for Developing Proteomic Biomarkers: A Case Study of Epithelial Ovarian Cancer.
Hüttenhain R; Choi M; Martin de la Fuente L; Oehl K; Chang CY; Zimmermann AK; Malander S; Olsson H; Surinova S; Clough T; Heinzelmann-Schwarz V; Wild PJ; Dinulescu DM; Niméus E; Vitek O; Aebersold R
Mol Cell Proteomics; 2019 Sep; 18(9):1836-1850. PubMed ID: 31289117
[TBL] [Abstract][Full Text] [Related]
20. S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer.
Wang XH; Zhang LH; Zhong XY; Xing XF; Liu YQ; Niu ZJ; Peng Y; Du H; Zhang GG; Hu Y; Liu N; Zhu YB; Ge SH; Zhao W; Lu AP; Li JY; Ji JF
Am J Pathol; 2010 Aug; 177(2):586-97. PubMed ID: 20581057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
